tykhr
sign in
free sign up
Anika Therapeutics Inc
Drug Manufacturers - Specialty & Generic
Healthcare
ANIK
14.33 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.34
52 week high
25.53
high
9.52
52 week low
0.00
low
9.07
growth
-64.24 %
previous Close
9.34
P/E ratio
market cap
120 M
div yield
0
usd
Jun 2025
qoq
revenue
28.22 M
7.84 %
net incoming
-3.97 M
18.53 %
eps
0.00 %
-116.67 %
eps surprise
-62.50 %
net profit margin
-14.07 %
4.00 %
operating incoming
-4.18 M
2.43 %
net change in cash
-204.00 K
94.61 %
cash on hand
53.17 M
-0.38 %
cost of revenue
13.86 M
20.62 %
top